Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 9, Pages e1409-e1409
Publisher
Springer Nature
Online
2014-09-04
DOI
10.1038/cddis.2014.343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-181b Promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients
- (2012) Baocan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
- (2012) Y.-T. Tai et al. BLOOD
- The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
- (2012) M. F. M. de Rooij et al. BLOOD
- Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
- (2012) Yao Dai et al. BMC CANCER
- Deletion of the Endothelial Bmx Tyrosine Kinase Decreases Tumor Angiogenesis and Growth
- (2012) T. Holopainen et al. CANCER RESEARCH
- BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB
- (2012) Stuart A. Rushworth et al. CELLULAR SIGNALLING
- PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies
- (2012) Eric S Winer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bruton’s Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies
- (2012) Yan Lou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells
- (2012) Y. Zhang et al. MOLECULAR CANCER RESEARCH
- The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils
- (2012) Fumiko Honda et al. NATURE IMMUNOLOGY
- DNA methylation silences miR-132 in prostate cancer
- (2012) A Formosa et al. ONCOGENE
- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
- (2011) S. E. M. Herman et al. BLOOD
- Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150
- (2011) M. Ghisi et al. BLOOD
- Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
- (2011) C-H Gattolliat et al. BRITISH JOURNAL OF CANCER
- Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation
- (2011) Zhenhua Zhang et al. CANCER BIOLOGY & THERAPY
- Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3
- (2011) Olga A. Guryanova et al. CANCER CELL
- Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development
- (2011) Shuyu Zhang et al. CARCINOGENESIS
- MicroRNA-494 Downregulates KIT and Inhibits Gastrointestinal Stromal Tumor Cell Proliferation
- (2011) W. K. Kim et al. CLINICAL CANCER RESEARCH
- p53 downregulates Down syndrome-associated DYRK1A through miR-1246
- (2011) Yu Zhang et al. EMBO REPORTS
- SwissParam: A fast force field generation tool for small organic molecules
- (2011) Vincent Zoete et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells
- (2011) Wei-Lin W Wang et al. Molecular Cancer
- SwissDock, a protein-small molecule docking web service based on EADock DSS
- (2011) A. Grosdidier et al. NUCLEIC ACIDS RESEARCH
- Tyrosine Kinase ETK/BMX Is Up-Regulated in Bladder Cancer and Predicts Poor Prognosis in Patients with Cystectomy
- (2011) Shengjie Guo et al. PLoS One
- The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
- (2011) Betty Y Chang et al. ARTHRITIS RESEARCH & THERAPY
- Role of Bruton’s tyrosine kinase in macrophage apoptosis
- (2010) Anupriya Khare et al. APOPTOSIS
- Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells
- (2010) B. Dai et al. CANCER RESEARCH
- Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells
- (2010) Xiao-Yan Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Effect of the Specific Src Family Kinase Inhibitor Saracatinib on Osteolytic Lesions Using the PC-3 Bone Model
- (2010) J. C. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein
- (2010) J Xiong et al. ONCOGENE
- ATM is down-regulated by N-Myc-regulated microRNA-421
- (2010) H. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures
- (2010) Andreas Kuglstatter et al. PROTEIN SCIENCE
- Primary B Cell Immunodeficiencies: Comparisons and Contrasts
- (2009) Mary Ellen Conley et al. Annual Review of Immunology
- Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
- (2009) A. Navarro et al. BLOOD
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase
- (2008) Wooyoung Hur et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started